[1] 中华医学会肝病学分会,中华医学会消化病学分会,中华医学会感染病学分会. 肝纤维化诊断和治疗共识(2019). 中华肝脏病杂志,2019,27(9):657-667.
[2] Tapper EB, Lok AS. Use of liver imaging and biopsy in clinical practice. N Engl J Med, 2017,377(8):756-768.
[3] Xu S, Wang Y, Tai DCS,et al. qFibrosis: a fully-quantitative innovative method incorporating histological features to facilitate accurate fibrosis scoring in animal model and chronic hepatitis B patients. J Hepatol, 2014,61(2):260-269.
[4] 张启迪,陆伦根. 无创肝纤维化/肝硬化评估技术的现状. 中华肝脏病杂志, 2018,26 (5): 325-327.
[5] Bellan M, Castello LM, Pirisi M. Candidate biomarkers of liver fibrosis: A concise,pathophysiology-oriented review.J Clin Transl Hepatol, 2018,6(3):317-325.
[6] Zeng MD, Lu LG, Mao YM, et al. Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a noninvasive model. Hepatology, 2005,42(6):1437-1445.
[7] Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology, 2003,38:518–526.
[8] Sterling RK, Lissen E, Clumeck N, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology, 2006,43:1317-1325.
[9] Kim WR, Berg T, Asselah T, et al. Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients. J Hepatol, 2016, 64(4): 773-780.
[10] 中华医学会感染病学分会 中华医学会肝病学分会.慢性乙型肝炎防治指南(2019年版)中华肝脏病杂志, 2019,27(12):938-961.
[11] Singh S, Muir AJ, Dieterich DT, et al. American Gastroenterological Association Institute Technical Review on the role of elastography in chronic liver diseases. Gastroenterology, 2017,152(6):1544-1577.
[12] Lim JK, Flamm SL, Singh S, et al. American Gastroenterological Association Institute Guideline on the role of elastography in the evaluation of liver fibrosis. Gastroenterology, 2017,152(6):1536-1543.
a) 中国肝炎防治基金会,中华医学会感染病学分会,中华医学会肝病学分会. 瞬时弹性成像技术诊断肝纤维化专家共识(2018年更新版). 中华肝脏病杂志,2019,27(3):182-191.
[13] Imajo K, Kessoku T, Honda Y, et al. Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography. Gastroenterology,2016,150(3):626-637.
[14] Liu J, Li Y, Yang X, et al. Comparison of two-dimensional shear wave elastography with nine serum fibrosis indices to assess liver fibrosis in patients with chronic hepatitis B: A prospective cohort study. Ultraschall Med,2019,40(2):237-246.
[15] Agbim U, Asrani S. Non-invasive assessment of liver fibrosis and prognosis: An update on serum and elastography markers. Expert Rev Gastroenterol Hepatol, 2019,13 (4), 361-374. |